3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
49
Lymphoid
37
Genitourinary
34
Other hematologic neoplasm
33
Gastrointestinal
32
Breast
26
Plasma cell
16
Gynecologic
14
CNS
13
Dermatologic
12
Head & Neck
11
Endocrine
10
Myeloid
10
Sarcoma
9
NET
5
Other solid neoplasm
5
Classical hematology
1
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
larotrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Tumor-Agnostic
×
1 year
×
Clear all
NCT02637687
2025-06-22
SCOUT
Bayer
Phase 1/2
Active not recruiting
154 enrolled
2 FDA